ライフサイエンスコーパス: retention in care

1 of providing ART at diagnosis: its impact on retention in care.

2 aternal ART initiation and mother and infant retention in care.

3 as no evidence of an effect on engagement or retention in care.

4 logical failure, immunological response, and retention in care.

5 at diagnosis may help to remove barriers to retention in care.

6 The primary study endpoint was retention in care 12 months after HIV testing with HIV-1

7 re significantly less likely to have optimal retention in care (adjusted odds ratio [aOR] 0.65, CI =

8 he role of voucher incentives on linkage and retention in care among DUs in India.

9 d recommendations to optimize entry into and retention in care and ART adherence for people with HIV.

10 cumented Hispanics achieved similar rates of retention in care and HIV suppression as documented Hisp

11 e intervention efforts are needed to improve retention in care and medication adherence so that more

12 We evaluated factors influencing retention in care and viral suppression in postpartum HI

13 n prespecified secondary outcomes, including retention in care and VL change.

14 Targets were missed for on-time pill pickup, retention in care, and virological suppression.

15 elling models, task shifting, linkage to and retention in care, antiretroviral therapy support, behav

16 Core indicators for retention in care are calculated based on attended HIV c

17 Antiretroviral therapy (ART) and retention in care are essential for the prevention of mo

18 that improve not just HIV screening but also retention in care are needed to optimize epidemiologic i

19 es are recommended to improve linkage to and retention in care are provided.

20 tcome of linkage to care within 1 month plus retention in care at 12 months after HIV-positive testin

21 nkage (2.5 days versus 7.5 days, p = 0.189), retention in care at 12 months regardless of time to lin

22 Outcomes assessed included retention in care at 6 weeks' post partum and uptake of

23 reening, linkage, and particularly improving retention in care, can substantially reduce the burden o

24 (HIV)-infected patients across time improves retention in care compared with existing standard of car

25 The primary outcome was a composite of retention in care (completed HIV primary care visits wit

26 Caution is warranted in relying solely upon retention in care core indicators for policy, clinical,

27 Retention in care for human immunodeficiency virus (HIV)

28 within 90 days of delivery), associated with retention in care (>/= 1 CD4 count or VL test in each 6-

29 hotherapy, and pharmacologic treatments, and retention in care in clinical community-based, pediatric

30 sualizing deficiencies in case detection and retention in care, in order to prioritize interventions.

31 Support for adherence and retention in care, individualized risk assessment and co

32 s are provided for monitoring entry into and retention in care, interventions to improve entry and re

33 Retention in care is an essential component of meeting t

34 Our study suggests that improving retention in care-possibly by decentralizing RHD service

35 Health Resources and Services Administration Retention in Care project.

36 The main outcome measures were retention in care (quarter years with at least one compl

37 ion between different RW service classes and retention in care (RiC) or viral suppression (VS).

38 ferrals after testing positive, and improved retention in care strategies are required to further red

39 itiation of ART </=90 d of study enrollment, retention in care, time to ART initiation, patient-level

40 with HIV infection, effective linkage to and retention in care, timely initiation of ART, and high le

41 effect of immediate (versus deferred) ART on retention in care using a regression discontinuity desig

42 roviral therapy (ART) delivery would improve retention in care, viral load suppression, and change in

43 Retention in care was measured by the IOM and DHHS core

44 Retention in care was the most significant barrier to ac

45 her means in order to optimize adherence and retention in care, whenever necessary.

46 d beneficial in this setting, as it improves retention in care with virologic suppression among patie